# CRISPR-Cas in actinomycetes: still a lot to be discovered

**Authors:** Lena Mitousis, Ewa Musiol-Kroll, Wolfgang Wohlleben

PMC · DOI: 10.1093/femsml/uqaf010 · 2025-06-12

## TL;DR

This paper reviews the limited understanding of CRISPR-Cas systems in actinomycetes, which are important for producing natural products in medicine and industry.

## Contribution

The paper highlights the under-researched role of CRISPR-Cas systems in actinomycetes and identifies new subtypes based on sequence data.

## Key findings

- CRISPR-Cas systems are present in about half of sequenced actinobacterial genomes.
- In silico analysis has revealed new CRISPR-Cas subtypes in actinomycetes.
- Experimental evidence suggests unique features in crRNA maturation and life-cycle dependent activity.

## Abstract

Actinomycetes are important producers of valuable natural products that are applied in medicine or industry. The enzymes necessary for the synthesis of those compounds are encoded in biosynthetic gene clusters (BGCs) in the genome. However, the discovery of new natural products or the improvement of production levels can be hindered by difficulties in genetic manipulation, since standard methods often do not or not efficiently work in actinomycetes. One possible explanation for this could be the presence of nucleic acid defense systems such as CRISPR-Cas. Even though there is a lot of research published about CRISPR-Cas systems in general, the knowledge about the function of CRISPR-Cas in actinomycetes is very limited. Based on sequence data it is known that CRISPR-Cas systems occur in around half of all sequenced actinobacterial genomes. Moreover, in silico analyses of those systems have led to the discovery of new subtypes. The few examples of experimental evidence of CRISPR-Cas activity in vivo or in vitro, however, point to some special features, regarding crRNA maturation or life-cycle dependent CRISPR-Cas activity. This short review draws attention to this neglected research area and highlights the available data about CRISPR-Cas in actinomycetes.

There is only very limited knowledge about the functions of CRISPR-Cas (immunity and beyond) in the important group of natural product producing actinomycetes

## Linked entities

- **Species:** Actinomycetes (taxon 1760)

## Full-text entities

- **Genes:** Cas9 [NCBI Gene 46806597]
- **Diseases:** tuberculosis (MESH:D014376), infection (MESH:D007239), diphtheria (MESH:D004165), type III-A (MESH:C536044), toxicity (MESH:D064420), I, III (MESH:C564683), type I-Ea (MESH:C531835)
- **Chemicals:** 5'-AAN-3' (-), polyketides (MESH:D061065), geosmin (MESH:C001278), beta-lactams (MESH:D047090), avermectin (MESH:C019264), nitrogen (MESH:D009584), aminoglycosides (MESH:D000617), macrolide (MESH:D018942), glycopeptides (MESH:D006020), tetracyclines (MESH:D013754), cyclic di-AMP (MESH:C528998), metal (MESH:D008670)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Mycobacterium canetti (species) [taxon 78331], Streptomyces coelicolor A3(2) (strain) [taxon 100226], Homo sapiens (human, species) [taxon 9606], Corynebacterium striatum (species) [taxon 43770], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Actinoalloteichus hoggarensis (species) [taxon 1470176], Saccharopolyspora spinosa (species) [taxon 60894], Mycobacterium sp. SM1 (species) [taxon 2816243], Mycobacterium heckeshornense (species) [taxon 110505], Frankia (genus) [taxon 1854], Vibrio cholerae (species) [taxon 666], Streptomyces lividans (species) [taxon 1916], Mycobacterium tuberculosis (species) [taxon 1773], Actinomyces naeslundii (species) [taxon 1655], Corynebacterium diphtheriae (species) [taxon 1717], Salinispora (genus) [taxon 168694], Streptomyces avermitilis (species) [taxon 33903], Streptococcus pyogenes (species) [taxon 1314]
- **Mutations:** Corynebacterium striatum

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12231136/full.md

---
Source: https://tomesphere.com/paper/PMC12231136